We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
-1.77%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$182M
Cap. Flow
+$196M
Cap. Flow %
44.13%
Top 10 Hldgs %
6.43%
Holding
973
New
423
Increased
176
Reduced
103
Closed
271

Top Buys

Rank Stock Value
1
ORLY icon
O'Reilly Automotive
ORLY
+$3.2M
2
DUOL icon
Duolingo
DUOL
+$3.1M
3
UNH icon
UnitedHealth
UNH
+$3.01M
4
XYL icon
Xylem
XYL
+$3M
5
RBLX icon
Roblox
RBLX
+$2.69M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.73M
2
GILD icon
Gilead Sciences
GILD
+$1.53M
3
AAL icon
American Airlines Group
AAL
+$1.36M
4
WDC icon
Western Digital
WDC
+$1.34M
5
EXE
Expand Energy Corp
EXE
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Financials 15.66%
3 Industrials 13.68%
4 Consumer Discretionary 13.18%
5 Healthcare 12.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFLY icon
651
Butterfly Network
BFLY
$1.89B
$99.8K 0.02%
26,257
-12,248
-32% -$33.3K
DNA icon
652
Ginkgo Bioworks
DNA
$528M
$99.7K 0.02%
+11,997
New +$129K
PBYI icon
653
Puma Biotechnology
PBYI
$404M
$98.7K 0.02%
+16,592
New +$88.1K
ZIP icon
654
ZipRecruiter
ZIP
$321M
$98.3K 0.02%
+25,216
New +$113K
CRVS icon
655
Corvus Pharmaceuticals
CRVS
$1.12B
$97K 0.02%
12,601
-14,450
-53% -$114K
CTKB icon
656
Cytek Biosciences
CTKB
$545M
$96.6K 0.02%
+19,124
New +$88.8K
MYGN icon
657
Myriad Genetics
MYGN
$270M
$96.5K 0.02%
15,691
+4,243
+37% +$30.8K
DMAC icon
658
DiaMedica Therapeutics
DMAC
$342M
$96.1K 0.02%
+12,070
New +$90.3K
AIRO
659
AIRO Group Holdings
AIRO
$212M
$95.6K 0.02%
+11,692
New +$151K
SWIM icon
660
Latham Group
SWIM
$629M
$95.6K 0.02%
+15,055
New +$105K
SSP icon
661
E.W. Scripps
SSP
$257M
$95K 0.02%
+23,820
New +$80.1K
PANL icon
662
Pangaea Logistics
PANL
$498M
$94.5K 0.02%
+13,730
New +$83K
ACH
663
Accendra Health
ACH
$237M
$92.9K 0.02%
33,178
-10,263
-24% -$36.7K
ALT icon
664
Altimmune
ALT
$552M
$92.8K 0.02%
25,701
+5,266
+26% +$23K
EVEX icon
665
Eve Holding
EVEX
$808M
$90.9K 0.02%
22,791
+8,580
+60% +$37.7K
CLOV icon
666
Clover Health Investments
CLOV
$2.2B
$89.3K 0.02%
+37,997
New +$104K
SGHT icon
667
Sight Sciences
SGHT
$286M
$89K 0.02%
+11,226
New +$71.7K
AVXL icon
668
Anavex Life Sciences
AVXL
$255M
$89K 0.02%
24,996
+5,895
+31% +$36.1K
NAGE
669
Niagen Bioscience
NAGE
$271M
$86.7K 0.02%
+13,636
New +$94.9K
HDSN
670
Hudson Technologies
HDSN
$254M
$85.2K 0.02%
+12,433
New +$98K
ORIC icon
671
Oric Pharmaceuticals
ORIC
$1.15B
$84.8K 0.02%
+10,366
New +$119K
III icon
672
Information Services Group
III
$199M
$81.8K 0.02%
+14,160
New +$79.5K
PRTH icon
673
Priority Technology Holdings
PRTH
$535M
$80K 0.02%
+14,679
New +$90.9K
BLND icon
674
Blend Labs
BLND
$431M
$79.2K 0.02%
26,053
-58,011
-69% -$185K
ERAS icon
675
Erasca
ERAS
$6.3B
$76.1K 0.02%
+20,459
New +$57.5K
25 26
27
28 29

Similar funds

PC
Permanens Capital New York $776M AUM 30.08% 1-Year Est. Return
TCM
Twin Capital Management Mcmurray, Pennsylvania $776M AUM 28.34% 1-Year Est. Return
BPIM
Brant Point Investment Management New York $776M AUM 41.18% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $775M AUM 18.57% 1-Year Est. Return
LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
BIA
Biondo Investment Advisors Milford, Pennsylvania $780M AUM 21.03% 1-Year Est. Return
SC
Sylebra Capital Palo Alto, California $774M AUM 56.69% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

AXQ Capital's Q4 2025 Portfolio in Review

As of Q4 2025, AXQ Capital held 973 positions worth $443M, up 70% from $261M the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

AXQ Capital deployed $196M of net new capital in Q4 2025, opening 423 new positions and adding to 176 existing holdings. Its largest new stake was O'Reilly Automotive: 32,736 shares worth $2.99M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Western Digital, an estimated $1.34M trimmed.

  • AXQ Capital's largest Q4 2025 buy was O'Reilly Automotive: 32,736 shares worth $2.99M.
  • AXQ Capital added most to Duolingo in Q4 2025, an estimated $3.1M increase.
  • AXQ Capital's biggest Q4 2025 reduction was Western Digital, cutting an estimated $1.34M.
  • AXQ Capital fully exited Bristol-Myers Squibb in Q4 2025, selling an estimated $1.73M.
  • AXQ Capital's ten largest holdings make up 6.4% of its $443M portfolio in Q4 2025.
  • AXQ Capital opened 423 new positions and closed 271 in Q4 2025.
  • AXQ Capital's portfolio value rose 70% quarter-over-quarter to $443M.

Based on AXQ Capital's 13F filing for Q4 2025, filed 10 Feb 2026.